Precision Biosciences DTIL
NASDAQ DTIL
$9.15 -0.35 (-3.68%)
At close: Nov 11, 2026 · 4:00 PM EST

Precision Biosciences (DTIL) Share-based Compensation (IS) (2025 - 2026)

Updated

Precision Biosciences (DTIL) recorded Share-based Compensation (IS) of $1.84 million in fiscal Q2 2026 (quarter ended Jun 30, 2026), down 37.2% from $2.94 million a year earlier.

Analysis

Precision Biosciences (DTIL) Share-based Compensation (IS) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Precision Biosciences 264.98 Mn -121.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.84 Mn
Jun 30, 2025 2.94 Mn
API Access

Precision Biosciences Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=DTIL&period=max&api_key=YOUR_API_KEY